Table 2.
Variable | Mesh (n= 69) | No mesh (n= 70) | P-value |
---|---|---|---|
Objective success (POP-Q stage 0 or 1)at 12 months of subjects returning forfollow up | 51/63 (81.0%) | 40/61 (65.6%) | 0.07* |
Objective success (POP-Q stage 0 or 1)at 12 months assuming subjects lost tofollow up as failures | 51/69 (73.9%) | 40/70 (57.1%) | 0.049* |
Objective success (POP-Q stage 0 or 1)at 12 months assuming subjects lost tofollow up as successes | 57/69 (82.6%) | 49/70 (70.0%) | 0.11* |
PSI-QOL, mean change from preoperativeto 12 months score** (SD) | −6.93 (±8.25) | −7.77 (±7.43) | 0.58*** |
No. subjects analysed | 55 | 53 | |
SUDI, mean change from preoperativeto 12 months score** (SD) | −20.4 (±29.5) | −17.6 (±30.9) | 0.62*** |
No. subjects analysed | 59 | 57 | |
SIIQ, mean change from preoperative to12 months score** (SD) | −17.3 (±30.9) | −15.0 (±33.2) | 0.76*** |
No. subjects analysed | 35 | 37 | |
CCCS, mean change from preoperativeto 12 months score** (SD) | −1.00 (±4.20) | −0.75 (±4.30) | 0.78*** |
No. subjects analysed | 50 | 44 | |
Subjects reporting a VAS for satisfactionwith surgery of ≥80/100 | 45/59 (91.5%) | 51/63 (81.0%) | 0.12* |
Awareness of prolapse | 3/61 (4.9%) | 7/62 (11.3%) | 0.32* |
Fisher’s exact test.
A negative change indicates a decrease in score over time and improved symptoms or impaired quality of life.
Two sample t-test for independent means.